In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa

Journal of Refractive Surgery

Volumn 25, Issue 9, 2009, Pages

  Schrier, Amilia ^a   Greebel, Gennifer ^b,c   Attia, Hosam ^b,c   Trokel, Stephen ^a   Smith, Edward F ^b,c  

^a Edward S Harkness Eye Institute   (United States)

^b Downstate Health Sciences University   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; DEXTRAN; RIBOFLAVIN;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; ULTRAVIOLET RADIATION;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; RIBOFLAVIN; STAPHYLOCOCCUS AUREUS; ULTRAVIOLET RAYS;

EID: 73249151562     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081597X-20090813-07     Document Type: Conference Paper

References (22)

1. Mah-Sadorra JH, Yavuz SG, Najjar DM, Laibson PR, Rapuano CJ, Cohen EJ. Trends in contact lens-related corneal ulcers. Cornea. 2005;24:51-58.
2. Chang DC, Grant GB, O'Donnell K, Wannemuehler KA, Noble-Wang J, Rao CY, Jacobson LM, Crowell CS, Sneed RS, Lewis FM, Schaffzin JK, Kainer MA, Genese CA, Alfonso EC, Jones DB, Srinivasan A, Fridkin SK, Park BJ; Fusarium Keratitis Investigation Team. Multistate outbreak of Fusarium keratitis associated with the use of contact lens solution. JAMA. 2006;296:953-963.
3. Alfonso EC, Miller D, Cantu-Dibildox J, O'Brien TP, Schein OD. Fungal keratitis associated with non-therapeutic soft contact lenses. Am J Ophthalmol. 2006;142:154-155.
4. Joslin CE, Tu EY, Shoff ME, Booton GC, Fuerst PA, McMahon TT, Anderson RJ, Dworkin MS, Sugar J, Davis FG, Stayner LT. The association of contact lens solution use and Acanthamoeba keratitis. Am J Ophthalmol. 2007;144:169-180.
5. Kanellopolous AJ, Binder PS. Collagen cross-linking (CCL) with sequential topography guided PRK: a temporizing alternative for keratoconus to penetrating keratoplasty. Cornea. 2007;26:891-895.
6. Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26:385-389.
7. Thiel M. Corneal cross linking and corneal ulcers. Presented at: Third International Congress of Corneal Cross-Linking; December 7-8, 2007; Zurich, Switzerland.
8. Moshirfar M, Mirzaian G, Feiz V, Kang PC. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refract Surg. 2006;32:515-518.
9. Kumar V, Lockerbie O, Keil SD, Ruane PH, Platz MS, Martin CB, Ravanat JL, Cadet J, Goodrich RP. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol. 2004;80:15-21.
10. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion. 2004;44:877-885.
11. Corbin F. Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer. Int J Hematol. 2002;76:253-257
12. Goodrich RP. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang. 2000;78:211-215.
13. Knutson F, Alfonso R, Dupuis K, Mayaudon V, Lin L, Corash L, Högman CF. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang. 2000;78:209-216.
14. Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang. 2006;90:85-91.
15. Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R. Pathogen inactivation of Trypanosome Cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apheresis Sci. 2007;37:131-137.
16. Pelletier JP, Transue S, Snyder EL. Pathogen inactivation techniques. Best Pract Res Clin Haematol. 2006;19:205-242.
17. Mohr H, Redecker-Klein A. Inactivation of pathogens in platelet concentrates by using a two-step procedure. Vox Sang. 2003;84:96-104.
18. Krishnamurthy K, Demirci A, Irudavari J. Inactivation of Staphylococcus aureus by pulsed UV-light sterilization. J Food Prot. 2004;67:1027-1030.
19. Vermeuler N, Keeler WJ, Nandakumar K, Leung KT. The bactericidal effect of ultraviolet and visible light on Escherichia coli. Biotechnol Bioeng. 2008;99:550-556.
20. Marangon FB, Miller D, Alfonso EC. Impact of prior therapy on the recovery and frequency of corneal pathogens. Cornea. 2004;23:158-164.
21. Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye. 1993;7:719-725.
22. Tanure MA, Cohen EJ, Sudesh S, Rapuano CJ, Laibson PR. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000;19:307-312.